Healthy Skepticism Library
Items published in 2003
There are 1200 items in the Healthy Skepticism Library that were published in 2003.
Page 10 of 12 pages ‹ First < 8 9 10 11 12 >
HSL1905
Potts M.
Two pills, two paths: a tale of gender bias.
Endeavour 2003; 27:(3):127-30
HSL1910
Motchane JL.
Health for all or riches for some: WHO's responsible?
Int J Health Serv 2003; 33:(2):395-400
HSL2044
Kay J.
The Truth about Markets: Why Some Nations are Rich but Most Remain Poor
London: Penguin Books 2003
http://www.penguin.co.uk/nf/Book/BookDisplay/0,,0_0140296727,00.html
HSL2235
Malugani M.
Want a Future in Pharmaceutical Sales?
2003
http://healthcare.monster.com/pharm/articles/pharmsales/
HSL2281
Hubbard R, Bayarri MJ.
Confusion over measures of evidence versus errors in classical statistical testing.
Am Statistician 2003; 57:171-182
HSL3692
Health Canada.
Health Protection Legislation. Detailed Legislative Proposal.
Ottawa: Health Canada. 2003
http://www2.itssti.hc-sc.gc.ca/HPCB/Policy/LegislativeRenewal.nsf/fb7c4e1fc0e11e1c85256d24006a12e5/b89331835ada362b85256d3d004f10f3/$FILE/WEBSITEENGLPROPOSALFINAL.pdf
HSL3808
Cohen D, Hoeller K.
Screening for depression: preventive medicine or telemarketing?
Ethical Hum Sci Serv 2003 Spr; 5:(1):3-6
HSL4809
Carr DM.
Pfizer's epidemic: a need for international regulation of human experimentation in developing countries.
Case West Reserve J Int Law 2003 Win; 35:(1):15-53
HSL4907
McCabe AR.
A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
Suffolk Univ Law Rev 2003; 36:(3):787-819
HSL5100
Breslow LH.
The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Harvard J Legis 2003 Win; 40:(1):133-93
HSL5292
Rossman G, Rallis S.
Learning in the Field. An Introduction to Qualitative Research. 2nd Edn
Thousand Oaks: Sage Publications 2003
HSL5429
Gilovich T, Griffin D, Kahneman D.
Heuristics and biases: The psychology of intuitive judgment
Cambridge: Cambridge University Press 2003
HSL5591
Russell FM, Shann F, Curtis N, Mulholland K.
Evidence on the use of paracetamol in febrile children.
Bull World Health Organ 2003; 81:(5):367-72
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003000500011&lng=en&nrm=iso&tlng=en
HSL19335
Stell LK.
Physicians' conflicts of interest.
APA Newsl Philos Med 2003; 3:(1):161-4
http://www.ncbi.nlm.nih.gov/pubmed/15115011
HSL7042
Eaton T. Fores Research Center
There Are No 'Chemical Imbalances'
2003
http://www.etfrc.com/ChemicalImbalances.htm
HSL7329
Pastakia S, Wertheimer AI.
Direct to consumer advertising of prescription vs. non-prescription drugs in the United States
Journal of Social and Administrative Pharmacy 2003; 20:(6):197-203
HSL7331
Direct-to-consumer advertising and patients
WHO Drug Information 2003; 17:(4):262-3
HSL7334
Gillat A.
Compulsory licensing to regulated licensing: effects on the conflict between innovation and access in the pharmaceutical industry.
Food Drug Law J 2003; 58:(4):711-40
HSL7335
Shaeffer J.
Prescription drug advertising--should states regulate what is false and misleading?
Food Drug Law J 2003; 58:(4):629-48
HSL7340
Levy S.
Will yuletide sales be torrid or tepid?
Drug Topics 2003; 147:(23):86-89
HSL7341
Monaghan MS, Turner PD, Houghton BL, Markert RJ, Rich EC, .
Pharmacotherapy cost comparison among health professional students
American Journal of Pharmaceutical Education 2003; 67:(3):
HSL7342
D'souza AO, Lively BT, Siganga W, Goodman MH.
Effects of direct-to-consumer advertising of prescription drugs: Perceptions of primary care physicians
Journal of Pharmaceutical Marketing and Management 2003; 15:(3):61-75
HSL7343
Shah S, Holmes ER, Desselle SP.
The use of persuasion in print DTC advertisements of prescription drugs: A content analysis of leading consumer magazines from 1995-2000
Journal of Pharmaceutical Marketing and Management 2003; 15:(3):23-43
HSL7344
Young HN.
'Look george, there's another one!' - The volume and characteristics of direct-to-consumer advertising in popular magazines
Journal of Pharmaceutical Marketing and Management 2003; 15:(3):7-21
HSL7345
Patel RA, Ravnan MC.
Consumer-directed advertising of prescription medications
California Journal of Health System Pharmacy 2003; 15:(6):15-18
HSL7346
Sax B.
Generic pain management continues to grow
Pharmacy Times 2003; 69:(11):
HSL7352
Schwartz A.
Why generics will benefit from today's trends
US Pharmacist 2003; 28:(11):3-4, 10-12
HSL7353
Santhouse A, Albano D.
Evaluation of Wyeth medical communications written responses and the impact on prescribing
Drug Information Journal 2003; 37:(4):445-450
HSL7413
Peppin P, Carty E.
Signs of inequality: constructing disability in antidepressant drug advertising.
Health Law Journal 2003; 11:(Special Ed):161-84
http://web.archive.org/web/20061010052207/http://www.law.ualberta.ca/centres/hli/pdfs/hlj/2003_Special/10_Peppin%20&%20Carty.pdf
HSL7448
Morin K, Morse LJ.
The ethics of pharmaceutical industry gift-giving: the role of a professional association.
Am J Bioeth 2003 Sum; 3:(3):54-5
http://www.ncbi.nlm.nih.gov/pubmed/14594494
HSL7538
Kaitin KI, Cairns C.
The new drug approvals of 1999, 2000, and 2001: Drug development trends a decade after passage of the Prescription Drug User Fee Act of 1992
Drug Information Journal 2003; 34:(7):357-371
HSL7540
Congress debates PBMs and medicare while FDA considers changes to DTC regulation
Formulary 2003; 38:(11):657-658
HSL7541
Chi J.
Discount cards are serving as safety net to many seniors
Drug Topics 2003; 147:(18):62
HSL7543
Kayne S.
New weapons in the fight against depression and breast cancer
New Zealand Pharmacy 2003; 23:(11):21
HSL7544
Holmes ER, Desselle SP.
The prevalence of informational appeals in direct-to-consumer advertisements of prescription drugs among leading consumer magazines
Journal of Social and Administrative Pharmacy 2003; 20:(4):132-141
HSL7547
Thompson A.
Patent expiries - How should they affect prescribing advice?
Pharmaceutical Journal 2003; 271:(7272):587-589
HSL7548
McNaughton EL, Goodridge CM.
The Canadian approach to freedom of expression and the regulation of food and drug advertising.
Food Drug Law J 2003; 58:(3):521-36
HSL7549
Blackwell AE, Beck JM
Drug manufacturers' First Amendment right to advertise and promote their products for off-label use: Avoiding a pyrrhic victory
Food and Drug Law Journal 2003; 58:(3):439-462
HSL7550
Evans GW, Friede AI
The Food and Drug Administration's regulation of prescription drug manufacturer speech: a First Amendment analysis.
Food Drug Law J. 2003; 58:(3):365-437
HSL7552
Kahan JS, Shapiro JK.
The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
Food Drug Law J 2003; 58:(3):353-64
HSL7554
Gilhooley M.
The Supreme Court checks out drug promotion restrictions.
Food Drug Law J 2003; 58:(3):347-52
HSL7555
Gibbs JN, Ferrari PL, Murphy AM;
Ripe for revision: Reassessing the constitutionality of Food and Drug Administration restrictions on protected speech
Food and Drug Law Journal 2003; 58:(3):331-345
HSL7557
Waxman HA.
A history of adverse drug experiences: Congress had ample evidence to support restrictions on the promotion of prescription drugs.
Food Drug Law J 2003; 58:(3):299-312
HSL7558
Wechsler J.
Regulators and legislators address pharmaceutical rules and coverage - FDA offers new policies to relate enforcement to product risk
Formulary 2003; 38:(10):606-7
HSL7564
Weems LK.
Importation and re-importation of prescription drugs: So what can we do about it?
Florida Pharmacy Today 2003; 68:(9):18
HSL7566
Casteuble T.
HDMA Foundation report surveys industry's barcode readiness
HealthCare Distributor 2003; 55:(4):15,17
HSL7606
Field RI.
Maine's plan to lower drug costs for the uninsured passes a major legal test
P and T 2003; 28:(9):593
HSL7607
Tsai AC.
Policies to regulate gifts to physicians from industry
JAMA 2003; 290:(13):1776
HSL7608
Tatchell M.
Free trade and the PBS
Pharmacy Review 2003; 27:(3):21-22
HSL7609
Trading in our health system?
Pharmacy Review 2003; 27:(3):19-21
HSL7610
Strict controls on advertising
Pharmacy Review 2003; 27:(3):14, 19
HSL7611
Free rein for drug ads?
Consumer Reports 2003; 68:(2):33-37
HSL7612
Koopmanschap MA, Rutten FF.
The drug budget silo mentality: The Dutch case
Value in Health 2003; 6:(4):46-51
HSL7613
Hurley D.
Federal guidance
Pharmacy Practice News 2003; 30:(7):
HSL7614
McCue MT.
The rock meets the hard place on drug prices and research
Managed Healthcare Executive 2003; 13:(8):1
HSL7615
Franquesa N.
APS: additional value in the pharmacy?
Farmaceutico El 2003; (295):66,68,70,72,
HSL7616
Johanson V.
The Pan aftermath - where to from here?
Australian Journal of Pharmacy 2003; 84:(1001):666-7
HSL7617
Moffitt CM, MacLean EA, Noris-sullivan V.
Helping seniors understand the healthcare system: A pharmacist directed educational series
ASHP Midyear Clinical Meeting 2003;
HSL7618
Drug advertising helps patients
Michigan Pharmacist 2003; 41:(4):39
HSL7619
Tsang JP.
Hospital to home
Pharmaceutical Executive 2003; 23:(7):84,86,88,90,92
HSL7620
Ho J.
Extending the product lifeline
Pharmaceutical Executive 2003; 23:(7):70,72,74,76
HSL7621
Schreiber C.
The pivotal prescribers
Pharmaceutical Executive 2003; 23:(7):62,64,66,68
HSL7622
Keeling P, Meade P.
How to make Rx-Dx alliances
Pharmaceutical Executive 2003; 23:(7):48,50,52,54,56,58,60
HSL7623
Wechsler J.
The push for generics challenges manufacturers
Pharmaceutical Technology 2003; 27:(7):26,28,30,32,34
HSL7624
Gaughan D.
Deficiencies observed during inspection
Irish Pharmacy Journal 2003; 81:(5):208-210
HSL7626
Direct-to-consumer drug advertising: survey results
WHO Drug Information 2003; 17:(1):15
HSL7630
Tatchell M.
Controlling drug expenditure in Europe
Pharmacy Review 2003; 27:(1):28-9
HSL7631
Murawski MM, Mychaskiw MA, Surdej J.
Exploration of the relationship between health-related quality of life and the price of pharmaceutical products
Drug Information Journal 2003; 37:(2):221-231
HSL7632
Vos LO.
Bring in the reinforcements
Pharmaceutical Executive 2003; 23:(5):82-83
HSL7633
A forlorn end to the PIIP scheme?
Australian Journal of Pharmacy 2003; 84:(998):348
HSL7634
Pal S.
More time needed for drug approvals
US Pharmacist 2003; 28:(5):12, 15
HSL7635
Tarnoff S, Kowalski G, Bauer B.
Neglected prescribers
Pharmaceutical Executive 2003; 23:(5):24,26,28
HSL7636
Perper E.
3-D marketing
Pharmaceutical Executive 2003; 23:(5):138,140,142,144
HSL7637
Frank RG.
Perspective - Government commitment and regulation of prescription drugs
Health Affairs 2003; 22:(3):46-48
HSL7638
DTC ad battle heals up
Pharmaceutical Executive 2003; 23:(5):22
HSL7639
Miller J.
Bar code requirement would lead to adoption of efficient technology
Managed Healthcare Executive 2003; 13:(5):42, 43, 45
HSL7642
Kalb PE, Dunlop KO, McEnroe DC, Stein SD.
Direct-to-consumer marketing: the Food and Drug Administration is not alone.
Food Drug Law J 2003; 58:(1):25-33
HSL7643
Rao DA, Srinivas S.
OTC status for prescription drugs
Pharma Times 2003; 35:(2):17-18
HSL7645
Waltz JA.
CMS report analyzes factors affecting the marketing of prescription drugs
Drug Benefit Trends 2003; 15:(3):23-24,27
HSL7646
Fridman GA, Zimerman CA, Bregni C.
Consumption of antidepressant and anxiolytic drugs in Argentina in 1998
Ars Pharmaceutica 2003; 43:(1-3):5-12
HSL7647
Barlas S.
Some drug ads don't "ad" up
P and T 2003; 28:(1):19
HSL7648
Novelli WD.
Shake hands on Rx drugs for Medicare
Pharmaceutical Executive 2003; 23:(2):18, 20
HSL7649
New obstacles slow efforts to speed generics to market
Drug Benefit Trends 2003; 15:(2):16-17
HSL7651
Trimble LT, Ashby DM, Geize SB, Thomasset KB.
Cost-benefit analysis of indigent care programs for inpatients in a large academic medical center
ASHP Summer Meeting 2003; 60:
HSL7653
Report criticizes FDA's oversight of DTC ads
American Journal of Health System Pharmacy 2003; 60:(2):122,126
HSL7841
Millenson M
Getting Doctors to Say Yes to Drugs: The Cost and Quality Impact of Drug Company Marketing to Physicians
: Blue Cross and Blue Shield Association 2003
http://web.archive.org/web/20071026063406/http://www.bcbs.com/betterknowledge/cost/Drug_Co_Marketing_Report.pdf
HSL7865
Flynn FJ.
What have you done for me lately? Temporal adjustments to favor evaluations.
Organizational Behavior and Human Decision Processes 2003; 91:(1):38-50
http://www.francisflynn.com/papers/WhatHaveYouDoneForMeLately.pdf
HSL19378
Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, Petticrew M, Altman DG; International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group.
Evaluating non-randomised intervention studies.
Health Technol Assess 2003; 7:(27):iii-x,
http://www.hta.ac.uk/execsumm/summ727.htm
HSL9703
Wechsler J.
Drug pricing concerns shape policy decisions
Pharmaceutical Technology Europe 2003; 15:(12):22-24
HSL9704
Albedo A.
One step further in EU medicine lobster quadrille
Pharmaceutical Technology Europe 2003; 15:(11):12-17
HSL9738
Backman J.
Use of antidepressants in deliberate self-poisoning - Psychiatric diagnoses and drugs used between 1987 and 1997 in Lund, Sweden
Social Psychiatry and Psychiatric Epidemiology 2003; 38:(12):684-689
http://link.springer-ny.com
HSL9779
Madsen S, Huse J, Roksvaag PO.
Pharmacy customers' attitude to generics
Tidsskrift for den Norske Laegeforening 2003; 123:(6):792-793
HSL9789
Akram G, Roberts K.
Pharmacists' management of over-the-counter medication requests from methadone patients
Journal of Substance Use 2003; 8:(4):215 - 222
HSL9793
Ekedahl A.
Unused Drugs Returned to Pharmacies - A Few Patients Return a Large Proportion of the Unused Drugs
Journal of Social and Administrative Pharmacy 2003; 20:(6):257-258
HSL9795
Overo J.
OTC antifungal drugs [2] (multiple letters)
Ugeskrift for Laeger 2003; 165:(9):933-934
HSL9879
Husain N.
Challenges for pharmacists in India
Pharmaceutical Journal 2003; 271:(7280):885-886
HSL9880
Mason P.
Pharmacy in Australia
Pharmaceutical Journal 2003; 271:(7280):883-884
HSL9881
Ludzker DH.
Let us not follow the United States [4]
Pharmaceutical Journal 2003; 271:(2779):812
HSL9882
Two developments widen availability of oseltamivir for 'flu
Pharmaceutical Journal 2003; 271:(7279):805
HSL9886
Work in progress
Veterinary Record 2003; 153:(25):761-762
Page 10 of 12 pages ‹ First < 8 9 10 11 12 >
